Singapore's Temasek invests in Sun Pharmaceutical

Singapore government-controlled investment group Temasek is not deterred by the experience of Daiichi Sankyo and Ranbaxy Laboratories. It has invested more than half a million dollars in Ranbaxy buyer Sun Pharmaceutical as well as other Indian drugmakers. More from FiercePharmaAsia

Suggested Articles

The FDA asked five drugmakers to pull their version of extended-release metformin off U.S. shelves after finding carcinogen contamination.

The FDA backtracked on its earlier testing and found NDMA contamination in the extended release formulation of certain generic versions of metformin.

GSK has formed several collaborations across the globe that will use its AS03 adjuvant to develop vaccines against the novel coronavirus.